ABEONA THERAPEUTICS INC. (ABEO) Form 424B3 — Jul 10, 2026
This prospectus supplement updates the list of selling stockholders to reflect the assignment of 760,870 Common Warrants from Point72 Associates, LLC to SILV Fund, Ltd. The total number of shares registered for resale remains up to 15,219,758, and this update does not alter the aggregate amount of securities registered under the shelf. Abeona Therapeutics will not receive any proceeds from the resale of the common stock by the selling stockholders. However, the company will receive proceeds from the cash exercise of any of the Common Warrants.
Key figures
- Offering Price
- $6.55
- Shares Offered
- 15,219,758
- Assigned Warrants
- 760870
- Warrant Assignment Source
- Point72 Associates, LLC
- Warrant Assignment Recipient
- SILV Fund, Ltd.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.